FDA
Optimark in Plastic Container
The FDA lists this product in 4 strengths and forms.
Composition
- Active ingredients
- GADOVERSETAMIDE 9927MG/30ML (330.9MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- GADOVERSETAMIDE 6618MG/20ML (330.9MG/ML) · InjectableNDA020976-004 · Discontinued
- GADOVERSETAMIDE 3309MG/10ML (330.9MG/ML) · InjectableNDA020976-002 · Discontinued
- GADOVERSETAMIDE 4963.5MG/15ML (330.9MG/ML) · InjectableNDA020976-003 · Discontinued
- GADOVERSETAMIDE 9927MG/30ML (330.9MG/ML) · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020976.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.



